P41156
Gene name |
Ets1 (Ets-1) |
Protein name |
Protein C-ets-1 |
Names |
p54 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:24356 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
331-415 (ETS domain) |
Relief mechanism |
Partner binding |
Assay |
|
Target domain |
331-415 (ETS domain) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
No accessory elements
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Garvie CW et al. (2002) "Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships", The Journal of biological chemistry, 277, 45529-36
- Nelson ML et al. (2010) "Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP", Proceedings of the National Academy of Sciences of the United States of America, 107, 10026-31
- Ning S et al. (2022) "The auto-inhibition mechanism of transcription factor Ets-1 induced by phosphorylation on the intrinsically disordered region", Computational and structural biotechnology journal, 20, 1132-1141
- Newman JA et al. (2015) "Structural insights into the autoregulation and cooperativity of the human transcription factor Ets-2", The Journal of biological chemistry, 290, 8539-49
- Samorodnitsky D et al. (2015) "A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1", The Journal of biological chemistry, 290, 22101-10
- Basuyaux JP et al. (1997) "The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner", The Journal of biological chemistry, 272, 26188-95
- Shiina M et al. (2015) "A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions", Journal of molecular biology, 427, 1655-69
- Babayeva ND et al. (2010) "Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA", Cell cycle (Georgetown, Tex.), 9, 3054-62
- Leprivier G et al. (2009) "Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter according to induced DNA bend orientation", Nucleic acids research, 37, 4341-52
Autoinhibited structure

Activated structure

1 structures for P41156
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P41156-F1 | Predicted | AlphaFoldDB |
No variants for P41156
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for P41156 |
No associated diseases with P41156
9 regional properties for P41156
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Zinc finger, TAZ-type | 346 - 432 | IPR000197-1 |
domain | Zinc finger, TAZ-type | 1766 - 1847 | IPR000197-2 |
domain | Zinc finger, ZZ-type | 1702 - 1751 | IPR000433 |
domain | Bromodomain | 1085 - 1195 | IPR001487 |
domain | Coactivator CBP, KIX domain | 586 - 666 | IPR003101 |
domain | CREB-binding protein/p300, atypical RING domain | 1193 - 1279 | IPR010303 |
domain | Nuclear receptor coactivator, CREB-bp-like, interlocking | 2016 - 2114 | IPR014744 |
conserved_site | Bromodomain, conserved site | 1109 - 1168 | IPR018359 |
domain | CBP/p300-type histone acetyltransferase domain | 1324 - 1701 | IPR031162 |
3 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
transcription regulator complex | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
15 GO annotations of molecular function
Name | Definition |
---|---|
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
DNA-binding transcription activator activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor binding | Binding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. |
histone acetyltransferase binding | Binding to an histone acetyltransferase. |
identical protein binding | Binding to an identical protein or proteins. |
nuclear receptor coactivator activity | A transcription coactivator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound nuclear receptor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. |
nucleic acid binding | Binding to a nucleic acid. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
RNA polymerase II-specific DNA-binding transcription factor binding | Binding to a sequence-specific DNA binding RNA polymerase II transcription factor, any of the factors that interact selectively and non-covalently with a specific DNA sequence in order to modulate transcription. |
sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
transcription cis-regulatory region binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon. |
transcription corepressor binding | Binding to a transcription corepressor, a protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription. Transcription corepressors do not bind DNA directly, but rather mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery. |
33 GO annotations of biological process
Name | Definition |
---|---|
angiogenesis involved in wound healing | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury. |
cell differentiation | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
cell motility | Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another. |
cellular response to hydrogen peroxide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
estrous cycle | A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur. |
female pregnancy | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
hypothalamus development | The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
negative regulation of inflammatory response | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
pituitary gland development | The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands. |
PML body organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of PML bodies, a class of nuclear body; they react against SP100 auto-antibodies (PML = promyelocytic leukemia). |
positive regulation of angiogenesis | Any process that activates or increases angiogenesis. |
positive regulation of blood vessel endothelial cell migration | Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of erythrocyte differentiation | Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of inflammatory response | Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
positive regulation of leukocyte adhesion to vascular endothelial cell | Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell. |
positive regulation of miRNA transcription | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
regulation of angiogenesis | Any process that modulates the frequency, rate or extent of angiogenesis. |
regulation of DNA-templated transcription | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
regulation of extracellular matrix disassembly | Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
response to estradiol | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
response to interleukin-1 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
response to laminar fluid shear stress | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls. |
response to mechanical stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
response to salt | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus. |
34 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A1A4L6 | ETS2 | Protein C-ets-2 | Bos taurus (Bovine) | SS |
Q2KIC2 | ETV1 | ETS translocation variant 1 | Bos taurus (Bovine) | SS |
P10157 | ETS2 | Protein C-ets-2 | Gallus gallus (Chicken) | SS |
Q90837 | ERG | Transcriptional regulator Erg | Gallus gallus (Chicken) | SS |
P13474 | ETS1 | Transforming protein p54/c-ets-1 | Gallus gallus (Chicken) | SS |
P15062 | ETS1 | Transforming protein p68/c-ets-1 | Gallus gallus (Chicken) | SS |
A2T762 | ETV3 | ETS translocation variant 3 | Pan troglodytes (Chimpanzee) | PR |
Q04688 | Ets97D | DNA-binding protein Ets97D | Drosophila melanogaster (Fruit fly) | PR |
P50548 | ERF | ETS domain-containing transcription factor ERF | Homo sapiens (Human) | PR |
P41970 | ELK3 | ETS domain-containing protein Elk-3 | Homo sapiens (Human) | SS |
P41161 | ETV5 | ETS translocation variant 5 | Homo sapiens (Human) | SS |
P43268 | ETV4 | ETS translocation variant 4 | Homo sapiens (Human) | EV |
Q06546 | GABPA | GA-binding protein alpha chain | Homo sapiens (Human) | SS |
P28324 | ELK4 | ETS domain-containing protein Elk-4 | Homo sapiens (Human) | EV |
P15036 | ETS2 | Protein C-ets-2 | Homo sapiens (Human) | EV |
P41162 | ETV3 | ETS translocation variant 3 | Homo sapiens (Human) | PR |
P50549 | ETV1 | ETS translocation variant 1 | Homo sapiens (Human) | EV |
P11308 | ERG | Transcriptional regulator ERG | Homo sapiens (Human) | EV |
P19419 | ELK1 | ETS domain-containing protein Elk-1 | Homo sapiens (Human) | EV |
P14921 | ETS1 | Protein C-ets-1 | Homo sapiens (Human) | EV |
P41971 | Elk3 | ETS domain-containing protein Elk-3 | Mus musculus (Mouse) | EV |
Q00422 | Gabpa | GA-binding protein alpha chain | Mus musculus (Mouse) | EV |
P41969 | Elk1 | ETS domain-containing protein Elk-1 | Mus musculus (Mouse) | PR |
P28322 | Etv4 | ETS translocation variant 4 | Mus musculus (Mouse) | SS |
P15037 | Ets2 | Protein C-ets-2 | Mus musculus (Mouse) | SS |
P70459 | Erf | ETS domain-containing transcription factor ERF | Mus musculus (Mouse) | PR |
Q9CXC9 | Etv5 | ETS translocation variant 5 | Mus musculus (Mouse) | SS |
P41158 | Elk4 | ETS domain-containing protein Elk-4 | Mus musculus (Mouse) | PR |
P41164 | Etv1 | ETS translocation variant 1 | Mus musculus (Mouse) | SS |
P81270 | Erg | Transcriptional regulator ERG | Mus musculus (Mouse) | SS |
P27577 | Ets1 | Protein C-ets-1 | Mus musculus (Mouse) | EV |
A4GTP4 | Elk1 | ETS domain-containing protein Elk-1 | Rattus norvegicus (Rat) | PR |
Q9PUQ1 | etv4 | ETS translocation variant 4 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
A3FEM2 | fev | Protein FEV | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MKAAVDLKPT | LTIIKTEKVD | LELFPSPDME | CADVPLLTPS | SKEMMSQALK | ATFSGFTKEQ |
70 | 80 | 90 | 100 | 110 | 120 |
QRLGIPKDPR | QWTETHVRDW | VMWAVNEFSL | KGVDFQKFCM | NGAALCALGK | ECFLELAPDF |
130 | 140 | 150 | 160 | 170 | 180 |
VGDILWEHLE | ILQKEDVKPY | QVNGVNPTYP | ESRYTSDYFI | SYGIEHAQCV | PPSEFSEPSF |
190 | 200 | 210 | 220 | 230 | 240 |
ITESYQTLHP | ISSEELLSLK | YENDYPSVIL | RDPLQTDTLQ | TDYFAIKQEV | LTPDNMCMGR |
250 | 260 | 270 | 280 | 290 | 300 |
ASRGKLGGQD | SFESIESYDS | CDRLTQSWSS | QSSFNSLQRV | PSYDSFDSED | YPAALPNHKP |
310 | 320 | 330 | 340 | 350 | 360 |
KGTFKDYVRD | RADLNKDKPV | IPAAALAGYT | GSGPIQLWQF | LLELLTDKSC | QSFISWTGDG |
370 | 380 | 390 | 400 | 410 | 420 |
WEFKLSDPDE | VARRWGKRKN | KPKMNYEKLS | RGLRYYYDKN | IIHKTAGKRY | VYRFVCDLQS |
430 | 440 | ||||
LLGYTPEELH | AMLDVKPDAD | E |